プロトンポンプ阻害薬（PPIs）の世界市場、2025-2029年

プロトンポンプ阻害薬（PPIs）市場は2024-2029年に8億1,950万米ドル、予測期間中のCAGRは4.7%で成長すると予測されます。

当レポートでは、プロトンポンプ阻害薬（PPIs）市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、薬剤の改良、処方率の伸び、胃食道逆流症の大流行によって牽引されています。

本調査では、今後数年間のプロトンポンプ阻害薬（ppis）市場成長を牽引する主要因の1つとして、老年人口の増加を挙げています。また、肥満の有病率の上昇と個別化されたPPI療法は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 Technavio分析

• 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
• インプットの重要性と差別化の要因
• 混乱の要因
• 促進要因と課題の影響

第3章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第4章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2024
• 市場の見通し 2024-2029

第5章 市場規模実績

• プロトンポンプ阻害薬（PPIs）の世界市場 2019-2023
• 製品セグメント分析 2019-2023
• 投与経路セグメント分析 2019-2023
• 地域別セグメント分析 2019-2023
• 国別セグメント分析 2019-2023

第6章 定性分析

• AIの影響：プロトンポンプ阻害薬（PPIs）の世界市場

第7章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第8章 市場セグメンテーション：製品別

• 市場セグメント
• 比較：製品別
• OTC PPI：市場規模と予測 2024-2029
• 処方PPI：市場規模と予測 2024-2029
• 市場機会：製品別

第9章 市場セグメンテーション：投与経路別

• 市場セグメント
• 比較：投与経路別
• オーラル：市場規模と予測 2024-2029
• 注射可能：市場規模と予測 2024-2029
• 市場機会：投与経路別

第10章 顧客情勢

• 顧客情勢の概要

第11章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2024-2029
• 欧州：市場規模と予測 2024-2029
• アジア：市場規模と予測 2024-2029
• 世界のその他の地域：市場規模と予測 2024-2029
• 米国：市場規模と予測 2024-2029
• ドイツ：市場規模と予測 2024-2029
• 中国：市場規模と予測 2024-2029
• カナダ：市場規模と予測 2024-2029
• インド：市場規模と予測 2024-2029
• 英国：市場規模と予測 2024-2029
• フランス：市場規模と予測 2024-2029
• 日本：市場規模と予測 2024-2029
• ブラジル：市場規模と予測 2024-2029
• アラブ首長国連邦：市場規模と予測 2024-2029
• 市場機会：地域情勢別

第12章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第13章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第14章 競合分析

• 企業プロファイル
• 企業ランキング指数
• 企業の市場ポジショニング
• Amgen Inc.
• AstraZeneca Plc
• Aurobindo Pharma Ltd.
• Bausch Health Companies Inc.
• Bayer AG
• Dr Reddys Laboratories Ltd.
• Eisai Co. Ltd.
• Eli Lilly and Co.
• Glenmark Pharmaceuticals Ltd.
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
• The Procter and Gamble Co.
• Zydus Lifesciences Ltd.

第15章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Company Market Positioning
• Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits11: Overview on criticality of inputs and factors of differentiation
• Exhibits12: Overview on factors of disruption
• Exhibits13: Impact of drivers and challenges in 2024 and 2029
• Exhibits14: Parent Market
• Exhibits15: Data Table on - Parent Market
• Exhibits16: Market characteristics analysis
• Exhibits17: Value chain analysis
• Exhibits18: Offerings of companies included in the market definition
• Exhibits19: Market segments
• Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ million)
• Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ million)
• Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%)
• Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
• Exhibits24: Historic Market Size - Data Table on Global Proton Pump Inhibitors (PPIs) Market 2019 - 2023 ($ million)
• Exhibits25: Historic Market Size - Product Segment 2019 - 2023 ($ million)
• Exhibits26: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
• Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ million)
• Exhibits29: Five forces analysis - Comparison between 2024 and 2029
• Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029
• Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029
• Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029
• Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029
• Exhibits35: Chart on Market condition - Five forces 2024 and 2029
• Exhibits36: Chart on Product - Market share 2024-2029 (%)
• Exhibits37: Data Table on Product - Market share 2024-2029 (%)
• Exhibits38: Chart on Comparison by Product
• Exhibits39: Data Table on Comparison by Product
• Exhibits40: Chart on OTC PPIs - Market size and forecast 2024-2029 ($ million)
• Exhibits41: Data Table on OTC PPIs - Market size and forecast 2024-2029 ($ million)
• Exhibits42: Chart on OTC PPIs - Year-over-year growth 2024-2029 (%)
• Exhibits43: Data Table on OTC PPIs - Year-over-year growth 2024-2029 (%)
• Exhibits44: Chart on Prescription PPIs - Market size and forecast 2024-2029 ($ million)
• Exhibits45: Data Table on Prescription PPIs - Market size and forecast 2024-2029 ($ million)
• Exhibits46: Chart on Prescription PPIs - Year-over-year growth 2024-2029 (%)
• Exhibits47: Data Table on Prescription PPIs - Year-over-year growth 2024-2029 (%)
• Exhibits48: Market opportunity by Product ($ million)
• Exhibits49: Data Table on Market opportunity by Product ($ million)
• Exhibits50: Chart on Route of Administration - Market share 2024-2029 (%)
• Exhibits51: Data Table on Route of Administration - Market share 2024-2029 (%)
• Exhibits52: Chart on Comparison by Route of Administration
• Exhibits53: Data Table on Comparison by Route of Administration
• Exhibits54: Chart on Oral - Market size and forecast 2024-2029 ($ million)
• Exhibits55: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
• Exhibits56: Chart on Oral - Year-over-year growth 2024-2029 (%)
• Exhibits57: Data Table on Oral - Year-over-year growth 2024-2029 (%)
• Exhibits58: Chart on Injectable - Market size and forecast 2024-2029 ($ million)
• Exhibits59: Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
• Exhibits60: Chart on Injectable - Year-over-year growth 2024-2029 (%)
• Exhibits61: Data Table on Injectable - Year-over-year growth 2024-2029 (%)
• Exhibits62: Market opportunity by Route of Administration ($ million)
• Exhibits63: Data Table on Market opportunity by Route of Administration ($ million)
• Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits65: Chart on Market share By Geographical Landscape 2024-2029 (%)
• Exhibits66: Data Table on Market share By Geographical Landscape 2024-2029 (%)
• Exhibits67: Chart on Geographic comparison
• Exhibits68: Data Table on Geographic comparison
• Exhibits69: Chart on North America - Market size and forecast 2024-2029 ($ million)
• Exhibits70: Data Table on North America - Market size and forecast 2024-2029 ($ million)
• Exhibits71: Chart on North America - Year-over-year growth 2024-2029 (%)
• Exhibits72: Data Table on North America - Year-over-year growth 2024-2029 (%)
• Exhibits73: Chart on Europe - Market size and forecast 2024-2029 ($ million)
• Exhibits74: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
• Exhibits75: Chart on Europe - Year-over-year growth 2024-2029 (%)
• Exhibits76: Data Table on Europe - Year-over-year growth 2024-2029 (%)
• Exhibits77: Chart on Asia - Market size and forecast 2024-2029 ($ million)
• Exhibits78: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
• Exhibits79: Chart on Asia - Year-over-year growth 2024-2029 (%)
• Exhibits80: Data Table on Asia - Year-over-year growth 2024-2029 (%)
• Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
• Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
• Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• Exhibits85: Chart on US - Market size and forecast 2024-2029 ($ million)
• Exhibits86: Data Table on US - Market size and forecast 2024-2029 ($ million)
• Exhibits87: Chart on US - Year-over-year growth 2024-2029 (%)
• Exhibits88: Data Table on US - Year-over-year growth 2024-2029 (%)
• Exhibits89: Chart on Germany - Market size and forecast 2024-2029 ($ million)
• Exhibits90: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
• Exhibits91: Chart on Germany - Year-over-year growth 2024-2029 (%)
• Exhibits92: Data Table on Germany - Year-over-year growth 2024-2029 (%)
• Exhibits93: Chart on China - Market size and forecast 2024-2029 ($ million)
• Exhibits94: Data Table on China - Market size and forecast 2024-2029 ($ million)
• Exhibits95: Chart on China - Year-over-year growth 2024-2029 (%)
• Exhibits96: Data Table on China - Year-over-year growth 2024-2029 (%)
• Exhibits97: Chart on Canada - Market size and forecast 2024-2029 ($ million)
• Exhibits98: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
• Exhibits99: Chart on Canada - Year-over-year growth 2024-2029 (%)
• Exhibits100: Data Table on Canada - Year-over-year growth 2024-2029 (%)
• Exhibits101: Chart on India - Market size and forecast 2024-2029 ($ million)
• Exhibits102: Data Table on India - Market size and forecast 2024-2029 ($ million)
• Exhibits103: Chart on India - Year-over-year growth 2024-2029 (%)
• Exhibits104: Data Table on India - Year-over-year growth 2024-2029 (%)
• Exhibits105: Chart on UK - Market size and forecast 2024-2029 ($ million)
• Exhibits106: Data Table on UK - Market size and forecast 2024-2029 ($ million)
• Exhibits107: Chart on UK - Year-over-year growth 2024-2029 (%)
• Exhibits108: Data Table on UK - Year-over-year growth 2024-2029 (%)
• Exhibits109: Chart on France - Market size and forecast 2024-2029 ($ million)
• Exhibits110: Data Table on France - Market size and forecast 2024-2029 ($ million)
• Exhibits111: Chart on France - Year-over-year growth 2024-2029 (%)
• Exhibits112: Data Table on France - Year-over-year growth 2024-2029 (%)
• Exhibits113: Chart on Japan - Market size and forecast 2024-2029 ($ million)
• Exhibits114: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
• Exhibits115: Chart on Japan - Year-over-year growth 2024-2029 (%)
• Exhibits116: Data Table on Japan - Year-over-year growth 2024-2029 (%)
• Exhibits117: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
• Exhibits118: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
• Exhibits119: Chart on Brazil - Year-over-year growth 2024-2029 (%)
• Exhibits120: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
• Exhibits121: Chart on UAE - Market size and forecast 2024-2029 ($ million)
• Exhibits122: Data Table on UAE - Market size and forecast 2024-2029 ($ million)
• Exhibits123: Chart on UAE - Year-over-year growth 2024-2029 (%)
• Exhibits124: Data Table on UAE - Year-over-year growth 2024-2029 (%)
• Exhibits125: Market opportunity By Geographical Landscape ($ million)
• Exhibits126: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits127: Impact of drivers and challenges in 2024 and 2029
• Exhibits128: Overview on criticality of inputs and factors of differentiation
• Exhibits129: Overview on factors of disruption
• Exhibits130: Impact of key risks on business
• Exhibits131: Companies covered
• Exhibits132: Company ranking index
• Exhibits133: Matrix on companies position and classification
• Exhibits134: Amgen Inc. - Overview
• Exhibits135: Amgen Inc. - Product / Service
• Exhibits136: Amgen Inc. - Key news
• Exhibits137: Amgen Inc. - Key offerings
• Exhibits138: SWOT
• Exhibits139: AstraZeneca Plc - Overview
• Exhibits140: AstraZeneca Plc - Product / Service
• Exhibits141: AstraZeneca Plc - Key news
• Exhibits142: AstraZeneca Plc - Key offerings
• Exhibits143: SWOT
• Exhibits144: Aurobindo Pharma Ltd. - Overview
• Exhibits145: Aurobindo Pharma Ltd. - Product / Service
• Exhibits146: Aurobindo Pharma Ltd. - Key offerings
• Exhibits147: SWOT
• Exhibits148: Bausch Health Companies Inc. - Overview
• Exhibits149: Bausch Health Companies Inc. - Business segments
• Exhibits150: Bausch Health Companies Inc. - Key news
• Exhibits151: Bausch Health Companies Inc. - Key offerings
• Exhibits152: Bausch Health Companies Inc. - Segment focus
• Exhibits153: SWOT
• Exhibits154: Bayer AG - Overview
• Exhibits155: Bayer AG - Business segments
• Exhibits156: Bayer AG - Key news
• Exhibits157: Bayer AG - Key offerings
• Exhibits158: Bayer AG - Segment focus
• Exhibits159: SWOT
• Exhibits160: Dr Reddys Laboratories Ltd. - Overview
• Exhibits161: Dr Reddys Laboratories Ltd. - Business segments
• Exhibits162: Dr Reddys Laboratories Ltd. - Key news
• Exhibits163: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibits164: Dr Reddys Laboratories Ltd. - Segment focus
• Exhibits165: SWOT
• Exhibits166: Eisai Co. Ltd. - Overview
• Exhibits167: Eisai Co. Ltd. - Business segments
• Exhibits168: Eisai Co. Ltd. - Key offerings
• Exhibits169: Eisai Co. Ltd. - Segment focus
• Exhibits170: SWOT
• Exhibits171: Eli Lilly and Co. - Overview
• Exhibits172: Eli Lilly and Co. - Product / Service
• Exhibits173: Eli Lilly and Co. - Key offerings
• Exhibits174: SWOT
• Exhibits175: Glenmark Pharmaceuticals Ltd. - Overview
• Exhibits176: Glenmark Pharmaceuticals Ltd. - Product / Service
• Exhibits177: Glenmark Pharmaceuticals Ltd. - Key offerings
• Exhibits178: SWOT
• Exhibits179: Pfizer Inc. - Overview
• Exhibits180: Pfizer Inc. - Product / Service
• Exhibits181: Pfizer Inc. - Key news
• Exhibits182: Pfizer Inc. - Key offerings
• Exhibits183: SWOT
• Exhibits184: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibits185: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibits186: Sun Pharmaceutical Industries Ltd. - Key news
• Exhibits187: Sun Pharmaceutical Industries Ltd. - Key offerings
• Exhibits188: SWOT
• Exhibits189: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibits190: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibits191: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibits192: Takeda Pharmaceutical Co. Ltd. - Key offerings
• Exhibits193: SWOT
• Exhibits194: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits195: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits196: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits197: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits198: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits199: SWOT
• Exhibits200: The Procter and Gamble Co. - Overview
• Exhibits201: The Procter and Gamble Co. - Business segments
• Exhibits202: The Procter and Gamble Co. - Key news
• Exhibits203: The Procter and Gamble Co. - Key offerings
• Exhibits204: The Procter and Gamble Co. - Segment focus
• Exhibits205: SWOT
• Exhibits206: Zydus Lifesciences Ltd. - Overview
• Exhibits207: Zydus Lifesciences Ltd. - Business segments
• Exhibits208: Zydus Lifesciences Ltd. - Key news
• Exhibits209: Zydus Lifesciences Ltd. - Key offerings
• Exhibits210: Zydus Lifesciences Ltd. - Segment focus
• Exhibits211: SWOT
• Exhibits212: Inclusions checklist
• Exhibits213: Exclusions checklist
• Exhibits214: Currency conversion rates for US$
• Exhibits215: Research methodology
• Exhibits216: Information sources
• Exhibits217: Data validation
• Exhibits218: Validation techniques employed for market sizing
• Exhibits219: Data synthesis
• Exhibits220: 360 degree market analysis
• Exhibits221: List of abbreviations

The proton pump inhibitors (PPIs) market is forecasted to grow by USD 819.5 mn during 2024-2029, accelerating at a CAGR of 4.7% during the forecast period. The report on the proton pump inhibitors (PPIs) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by reformulation of drugs, growth in prescription rate, and strong prevalence of gastroesophageal reflux disease.

Technavio's proton pump inhibitors (PPIs) market is segmented as below:

By Product

• OTC PPIs
• Prescription PPIs

By Route Of Administration

• Oral
• Injectable

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing geriatric population as one of the prime reasons driving the proton pump inhibitors (PPIs) market growth during the next few years. Also, rising prevalence of obesity and personalized ppi therapy will lead to sizable demand in the market.

The report on the proton pump inhibitors (PPIs) market covers the following areas:

• Proton Pump Inhibitors (PPIs) Market sizing
• Proton Pump Inhibitors (PPIs) Market forecast
• Proton Pump Inhibitors (PPIs) Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading proton pump inhibitors (PPIs) market vendors that include Amgen Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Bausch Health Companies Inc., Bayer AG, Cipla Inc., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Eli Lilly and Co., Glenmark Pharmaceuticals Ltd., Johnson and Johnson Inc., Perrigo Co. Plc, Pfizer Inc., RedHill Biopharma Ltd., Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., The Procter and Gamble Co., and Zydus Lifesciences Ltd.. Also, the proton pump inhibitors (PPIs) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Route of Administration
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Proton Pump Inhibitors (PPIs) Market 2019 - 2023
  • Historic Market Size - Data Table on Global Proton Pump Inhibitors (PPIs) Market 2019 - 2023 ($ million)
• 5.2 Product segment analysis 2019 - 2023
  • Historic Market Size - Product Segment 2019 - 2023 ($ million)
• 5.3 Route of Administration segment analysis 2019 - 2023
  • Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
• 5.4 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.5 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 The AI impact on Global Proton Pump Inhibitors (PPIs) Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

• 8.1 Market segments
  • Chart on Product - Market share 2024-2029 (%)
  • Data Table on Product - Market share 2024-2029 (%)
• 8.2 Comparison by Product
  • Chart on Comparison by Product
  • Data Table on Comparison by Product
• 8.3 OTC PPIs - Market size and forecast 2024-2029
  • Chart on OTC PPIs - Market size and forecast 2024-2029 ($ million)
  • Data Table on OTC PPIs - Market size and forecast 2024-2029 ($ million)
  • Chart on OTC PPIs - Year-over-year growth 2024-2029 (%)
  • Data Table on OTC PPIs - Year-over-year growth 2024-2029 (%)
• 8.4 Prescription PPIs - Market size and forecast 2024-2029
  • Chart on Prescription PPIs - Market size and forecast 2024-2029 ($ million)
  • Data Table on Prescription PPIs - Market size and forecast 2024-2029 ($ million)
  • Chart on Prescription PPIs - Year-over-year growth 2024-2029 (%)
  • Data Table on Prescription PPIs - Year-over-year growth 2024-2029 (%)
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)
  • Data Table on Market opportunity by Product ($ million)

9 Market Segmentation by Route of Administration

• 9.1 Market segments
  • Chart on Route of Administration - Market share 2024-2029 (%)
  • Data Table on Route of Administration - Market share 2024-2029 (%)
• 9.2 Comparison by Route of Administration
  • Chart on Comparison by Route of Administration
  • Data Table on Comparison by Route of Administration
• 9.3 Oral - Market size and forecast 2024-2029
  • Chart on Oral - Market size and forecast 2024-2029 ($ million)
  • Data Table on Oral - Market size and forecast 2024-2029 ($ million)
  • Chart on Oral - Year-over-year growth 2024-2029 (%)
  • Data Table on Oral - Year-over-year growth 2024-2029 (%)
• 9.4 Injectable - Market size and forecast 2024-2029
  • Chart on Injectable - Market size and forecast 2024-2029 ($ million)
  • Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
  • Chart on Injectable - Year-over-year growth 2024-2029 (%)
  • Data Table on Injectable - Year-over-year growth 2024-2029 (%)
• 9.5 Market opportunity by Route of Administration
  • Market opportunity by Route of Administration ($ million)
  • Data Table on Market opportunity by Route of Administration ($ million)

10 Customer Landscape

• 10.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

• 11.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 11.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 11.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 11.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 11.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 11.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 11.7 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ million)
  • Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 11.8 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 11.9 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ million)
  • Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 11.10 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 11.11 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ million)
  • Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 11.12 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 11.13 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ million)
  • Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 11.14 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 11.15 Brazil - Market size and forecast 2024-2029
  • Chart on Brazil - Market size and forecast 2024-2029 ($ million)
  • Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
  • Chart on Brazil - Year-over-year growth 2024-2029 (%)
  • Data Table on Brazil - Year-over-year growth 2024-2029 (%)
• 11.16 UAE - Market size and forecast 2024-2029
  • Chart on UAE - Market size and forecast 2024-2029 ($ million)
  • Data Table on UAE - Market size and forecast 2024-2029 ($ million)
  • Chart on UAE - Year-over-year growth 2024-2029 (%)
  • Data Table on UAE - Year-over-year growth 2024-2029 (%)
• 11.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

• 12.1 Market drivers
• 12.2 Market challenges
• 12.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 12.4 Market opportunities/restraints

13 Competitive Landscape

• 13.1 Overview
• 13.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 13.3 Landscape disruption
  • Overview on factors of disruption
• 13.4 Industry risks
  • Impact of key risks on business

14 Competitive Analysis

• 14.1 Companies profiled
  • Companies covered
• 14.2 Company ranking index
  • Company ranking index
• 14.3 Market positioning of companies
  • Matrix on companies position and classification
• 14.4 Amgen Inc.
  • Amgen Inc. - Overview
  • Amgen Inc. - Product / Service
  • Amgen Inc. - Key news
  • Amgen Inc. - Key offerings
  • SWOT
• 14.5 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
  • SWOT
• 14.6 Aurobindo Pharma Ltd.
  • Aurobindo Pharma Ltd. - Overview
  • Aurobindo Pharma Ltd. - Product / Service
  • Aurobindo Pharma Ltd. - Key offerings
  • SWOT
• 14.7 Bausch Health Companies Inc.
  • Bausch Health Companies Inc. - Overview
  • Bausch Health Companies Inc. - Business segments
  • Bausch Health Companies Inc. - Key news
  • Bausch Health Companies Inc. - Key offerings
  • Bausch Health Companies Inc. - Segment focus
  • SWOT
• 14.8 Bayer AG
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key news
  • Bayer AG - Key offerings
  • Bayer AG - Segment focus
  • SWOT
• 14.9 Dr Reddys Laboratories Ltd.
  • Dr Reddys Laboratories Ltd. - Overview
  • Dr Reddys Laboratories Ltd. - Business segments
  • Dr Reddys Laboratories Ltd. - Key news
  • Dr Reddys Laboratories Ltd. - Key offerings
  • Dr Reddys Laboratories Ltd. - Segment focus
  • SWOT
• 14.10 Eisai Co. Ltd.
  • Eisai Co. Ltd. - Overview
  • Eisai Co. Ltd. - Business segments
  • Eisai Co. Ltd. - Key offerings
  • Eisai Co. Ltd. - Segment focus
  • SWOT
• 14.11 Eli Lilly and Co.
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Product / Service
  • Eli Lilly and Co. - Key offerings
  • SWOT
• 14.12 Glenmark Pharmaceuticals Ltd.
  • Glenmark Pharmaceuticals Ltd. - Overview
  • Glenmark Pharmaceuticals Ltd. - Product / Service
  • Glenmark Pharmaceuticals Ltd. - Key offerings
  • SWOT
• 14.13 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT
• 14.14 Sun Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Product / Service
  • Sun Pharmaceutical Industries Ltd. - Key news
  • Sun Pharmaceutical Industries Ltd. - Key offerings
  • SWOT
• 14.15 Takeda Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Takeda Pharmaceutical Co. Ltd. - Key news
  • Takeda Pharmaceutical Co. Ltd. - Key offerings
  • SWOT
• 14.16 Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key news
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Segment focus
  • SWOT
• 14.17 The Procter and Gamble Co.
  • The Procter and Gamble Co. - Overview
  • The Procter and Gamble Co. - Business segments
  • The Procter and Gamble Co. - Key news
  • The Procter and Gamble Co. - Key offerings
  • The Procter and Gamble Co. - Segment focus
  • SWOT
• 14.18 Zydus Lifesciences Ltd.
  • Zydus Lifesciences Ltd. - Overview
  • Zydus Lifesciences Ltd. - Business segments
  • Zydus Lifesciences Ltd. - Key news
  • Zydus Lifesciences Ltd. - Key offerings
  • Zydus Lifesciences Ltd. - Segment focus
  • SWOT

15 Appendix

• 15.1 Scope of the report
• 15.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 15.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 15.4 Research methodology
  • Research methodology
• 15.5 Data procurement
  • Information sources
• 15.6 Data validation
  • Data validation
• 15.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 15.8 Data synthesis
  • Data synthesis
• 15.9 360 degree market analysis
  • 360 degree market analysis
• 15.10 List of abbreviations
  • List of abbreviations